In this Opto Sessions episode, Arelis Agosto, Senior Healthcare Analyst at Global X, discusses how non-traditional healthcare companies, including Nvidia, are propelling innovation in the space, with healthcare now being recognised as the world's foremost data-generating industry.

► Read the full article: www.cmcmarkets.com/en/opto/global-xs-arelis-agosto…

► Subscribe to our channel:
   / @optothemes  

Check out our podcast and subscribe, so you don't miss an episode:
► Apple Podcasts: podcasts.apple.com/gb/podcast...
► Spotify: open.spotify.com/show/4okyrCp...

►Want further Opto insights? Check out our daily newsletter: www.cmcmarkets.com/en/opto/newsletter

#shortvideo #bigdata #healthcare #digitalhealthcare #nvidia #financepodcast #shortsfeed
------------------
Past performance is not a reliable indicator of future results. CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment, or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction, or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination. CMC Markets does not endorse or offer opinions on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.